With several patients already enrolled in the study, PRISM PMR is designed to evaluate the Swoop® system’s clinical utility in the operating room.

Hyperfine, Inc. , the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—announced plans for clinical use expansion into the operating room environment, advancing its mission to make brain MRI more accessible across a diversity of care settings. The company plans to establish a foothold in the neurosurgical operating setting by launching a new study to build a body of clinical evidence for Swoop® system use in neurosurgical procedures.

Health Technology Insights: Prolink Names Vanessa Janus Chief Workforce Solutions Officer

“The PRISM PMR study and Dr. Levy’s pioneering work illustrates how the Swoop® system can potentially reshape neurosurgical care.”

PRISM PMR is designed to further collect data and optimize the Swoop® system’s real-world clinical utility in the operating room. The study will evaluate the pre- and post-procedure use of portable MRI across a diverse range of neurosurgical procedures, including its ability to detect post-operative complications, such as stroke and bleeding, and how it can be best integrated into the surgical workflow to accelerate discharge and recovery. The study has enrolled its first patients and is led by the principal investigator, Dr. Elad Levy, MD, MBA, a globally recognized pioneer in the field of neurovascular disease. It is being conducted over three months at the Atlas Surgery Center in Buffalo, New York.

Health Technology Insights: Pelage Pharmaceuticals Raises $120 Million Series B to Boost Hair Loss Treatments

“The operating room is an exciting new setting and use case for the portable MRI market. Having a high-field MRI right in the OR is not practical. The PRISM PMR study and Dr. Levy’s pioneering work illustrates how the Swoop® system can potentially reshape neurosurgical care, bringing valuable clinical insights and workflow benefits,” said Hyperfine President and Chief Executive Officer Maria Sainz. “By enabling neurosurgeons to obtain critical imaging immediately before and after a procedure, the Swoop® system can help improve patient safety, reduce costs, and transform how surgical centers think about imaging infrastructure.”

Dr. Levy commented, “MRI is a cornerstone in imaging patients undergoing neurovascular procedures, and having the ability to perform imaging immediately after surgery in the operating room is transformative,” said Dr. Elad Levy, neurosurgeon at Atlas Surgery Center. “Portable brain MRI allows us to confirm results, rule out major complications, and potentially safely discharge patients on the same day. This technology has the potential to redefine surgical workflows and change how we care for patients. It’s also helping us eliminate bottlenecks by shifting appropriate patients to the ambulatory setting, which in turn frees up valuable surgical capacity in the hospital.”

In addition to being part of the PRISM PMR study, Dr. Levy recently highlighted the value of having post-operative MRI on a live surgery case at the Congress of Neurological Surgeons, demonstrating the growing clinical interest and relevance of portable brain MRI in a surgical setting. Using the Swoop system post-procedure allowed Dr. Levy and his team to assess the intracranial environment, rule out complications, and support the possibility of same-day discharge—capabilities traditionally limited to hospitals equipped with large, costly intraoperative MRI systems requiring specialized siting and infrastructure.

Health Technology Insights: Micro Interventional Devices Gets FDA Nod for STTAR-US Trial

To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com

Source- businesswire